Sterling Investment Advisors, Ltd. Invitae Corp Transaction History

Sterling Investment Advisors, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$2.13 - $9.01 $2,130 - $9,010	-1,000 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$6.28 - $15.59 $2,260 - $5,612	360 Added 56.25%	1,000 $8,000
Q2 2021 Jul 29, 2021	SELL	$26.09 - $40.4 $726,867 - $1.13 Million	-27,860 Reduced 97.75%	640 $22,000
Q1 2021 May 04, 2021	BUY	$33.06 - $56.93 $36,531 - $62,907	1,105 Added 4.03%	28,500 $1.09 Million
Q4 2020 Jan 21, 2021	SELL	$39.09 - $57.4 $37,135 - $54,530	-950 Reduced 3.35%	27,395 $1.15 Million
Q3 2020 Oct 26, 2020	BUY	$28.43 - $44.67 $612,524 - $962,415	21,545 Added 316.84%	28,345 $1.23 Million
Q2 2020 Jul 24, 2020	BUY	$11.71 - $30.29 $79,628 - $205,972	6,800 New	6,800 $205,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.